Are all effects of esmolol equally rapid in onset?
The purpose of this study was to compare the time course of the bradycardic and hypotensive effects of esmolol. Ten patients undergoing craniotomy requiring hypotension were anesthetized with nitrous oxide and isoflurane. During steady state anesthesia, the response to an infusion of esmolol 500 micrograms.kg-1.min-1 for 90 s followed by 300 micrograms.kg-1.min-1 was measured over 60 min. Heart rate (HR), mean arterial pressure (MAP), and plasma renin activity (PRA) responses did not occur with equal rapidity. The half-time for the 14% decrease in HR (81 +/- 13 bpm to 70 +/- 9 bpm) was 1.2 min. MAP decreased by 26% (85 +/- 7 mm Hg to 63 +/- 6 mm Hg) with a 17.8 min half-time. This delay in MAP response may, in part, be related to the gradual 44% decline in PRA (9.5 +/- 4.5 ng.mL-1.h-1 to 5.3 +/- 2.5 ng.mL-1.h-1) occurring with a half-time of 11.9 min. The times to attainment of 90% maximum decreases were 4.8 +/- 3.0 min for HR, 42.5 +/- 8.9 min for MAP, and 32.1 +/- 15.0 min for PRA. Thus although esmolol has an ultrashort kinetic half-life, only the HR effect can be considered to have an ultrashort onset.
Ornstein
E
E
Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Young
W L
WL
Ostapkovich
N
N
Matteo
R S
RS
Diaz
J
J
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000769:Anesthesia, Inhalation; D001794:Blood Pressure / Q000187:drug effects; D001919:Bradycardia / Q000503:physiopathology; D003399:Craniotomy; D006207:Half-Life; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000503:physiopathology; D007023:Hypotension, Controlled; D007530:Isoflurane; D009609:Nitrous Oxide; D011412:Propanolamines / Q000494:pharmacology*; D012083:Renin / Q000097:blood; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D007530:Isoflurane; D012083:Renin; D009609:Nitrous Oxide; C036604:esmolol